• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Apria Inc.

    2/4/22 9:17:12 AM ET
    $APR
    Medical/Dental Instruments
    Health Care
    Get the next $APR alert in real time by email
    SC 13G 1 apriainc13g.htm SC 13G
     
    United States
    Securities and Exchange Commission
    Washington, D.C.  20549
       
       
    SCHEDULE 13G
       
    Under the Securities Exchange Act of 1934
       
    (Amendment No.   )*
       
     
     
    APRIA, INC.
    (Name of Issuer)
     
     
    COMMON STOCK
    (Title of Class of Securities)
     
     
    03836A101
    (CUSIP Number)
       
     
    DECEMBER 31, 2021
    (Date of Event Which Requires Filing of this Statement)
       
       
       
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
       
    [ X ]
    Rule 13d-1(b)
    [     ]
    Rule 13d-1(c)
    [     ]
    Rule 13d-1(d)
         
         
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information  required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     
    Page 1 of 8 Pages

     
     
    CUSIP No.  03836A101
     
     
    1.
     
    Names of Reporting Persons
     
    American Century Investment Management, Inc.
     
     
    2.
     
    Check the Appropriate Box if a Member of a Group (See Instructions)
     
           
     
    (a)
    [       ]
     
           
     
    (b)
    [       ]
     
     
     
    3.
     
    SEC Use Only
     
     
     
     
    4.
     
    Citizenship or Place of Organization
     
    Delaware
     
     
     
     
    5.
     
    Sole Voting Power
     
    2,036,435
           
    Number of Shares
    Beneficially
     
    6.
     
    Shared Voting Power
     
    N/A
    Owned by
         
    Each
    Reporting
     
    7.
     
    Sole Dispositive Power
     
    2,078,951
    Person With:
         
     
     
    8.
     
    Shared Dispositive Power
     
     
    N/A
       
    9.
    Aggregate Amount Beneficially Owned by Each Reporting Person
     
    2,078,951
         
    10.
    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) [     ]
     
     
         
    11.
    Percent of Class Represented by Amount in Row (9)
     
    5.86%
         
    12.
    Type of Reporting Person (See Instructions)
     
    IA
     
     
    Page 2 of 8 pages
     

     
     
    CUSIP No.  03836A101
     
     
    1.
     
    Names of Reporting Persons
     
    American Century Companies, Inc.
     
     
    2.
     
    Check the Appropriate Box if a Member of a Group (See Instructions)
     
           
     
    (a)
    [       ]
     
           
     
    (b)
    [       ]
     
     
     
    3.
     
    SEC Use Only
     
     
     
     
    4.
     
    Citizenship or Place of Organization
     
    Delaware
     
     
     
     
    5.
     
    Sole Voting Power
     
    2,036,435
           
    Number of Shares
    Beneficially
     
    6.
     
    Shared Voting Power
     
    N/A
    Owned by
         
    Each
    Reporting
     
    7.
     
    Sole Dispositive Power
     
    2,078,951
    Person With:
         
     
     
    8.
     
    Shared Dispositive Power
     
     
    N/A
       
    9.
    Aggregate Amount Beneficially Owned by Each Reporting Person
     
    2,078,951
         
    10.
    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
     (See Instructions) [     ]
     
     
         
    11.
    Percent of Class Represented by Amount in Row (9)
     
    5.86%
         
    12.
    Type of Reporting Person (See Instructions)
     
    HC
     
     
    Page 3 of 8 pages
     

     
     
    CUSIP No.  03836A101
     
     
    1.
     
    Names of Reporting Persons
     
    Stowers Institute for Medical Research
     
     
    2.
     
    Check the Appropriate Box if a Member of a Group (See Instructions)
     
           
     
    (a)
    [       ]
     
           
     
    (b)
    [       ]
     
     
     
    3.
     
    SEC Use Only
     
     
     
     
    4.
     
    Citizenship or Place of Organization
     
    Delaware
     
     
     
     
    5.
     
    Sole Voting Power
     
    2,036,435
           
    Number of Shares
    Beneficially
     
    6.
     
    Shared Voting Power
     
    N/A
    Owned by
         
    Each
    Reporting
     
    7.
     
    Sole Dispositive Power
     
    2,078,951
    Person With:
         
     
     
    8.
     
    Shared Dispositive Power
     
     
    N/A
       
    9.
    Aggregate Amount Beneficially Owned by Each Reporting Person
     
    2,078,951
         
    10.
    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) [     ]
     
     
         
    11.
    Percent of Class Represented by Amount in Row (9)
     
    5.86%
         
    12.
    Type of Reporting Person (See Instructions)
     
    HC
     
     
    Page 4 of 8 pages
     

     
     
    Item 1.
     
    (a)
    Name of Issuer.
     
     
    Apria, Inc.
     
     
    (b)
    Address of Issuer’s Principal Executive Offices
     
     
    7353 Company Drive
    Indianapolis, Indiana 46237
     
    Item 2.
     
    (a)
    Name of Person Filing.
       
     
    (1)
    American Century Investment Management, Inc.
     
     
    (2)
    American Century Companies, Inc.
     
      (3) Stowers Institute for Medical Research
         
         
    (b)
    Address of Principal Business Office or, if none, Residence.
       
     
    4500 Main Street
    9th Floor
    Kansas City, Missouri  64111
       
       
    (c)
    Citizenship.
         
     
    (1)
    Delaware
     
     
    (2)
    Delaware
     
      (3)    Delaware
       
       
    (d)
    Title of Class of Securities.
       
     
    Reference is made to the cover page of this filing.
       
       
    (e)
    CUSIP Number.
       
     
    Reference is made to the cover page of this filing.
     
    Page 5 of 8 pages

     
     
    Item 3.
    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
       
     
    (1)
    American Century Investment Management, Inc. is an investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
         
     
    (2)
    American Century Companies, Inc. is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
         
      (3) Stowers Institute for Medical Research, is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
         
       
    Item 4.
    Ownership.
       
     
    Reference is made to Items 5-9 and 11 on the cover page of this filing.
       
       
    Item 5.
    Ownership of Five Percent or Less of a Class.
       
     
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [      ].
       
       
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.
       
     
    Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. (“ACIM”) serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule.  Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
       
       
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
       
     
    See attached Exhibit A.
       
       
    Item 8.
    Identification and Classification of Members of the Group.
       
     
    Not applicable.
       
       
    Item 9.
    Notice of Dissolution of Group.
       
     
    Not applicable.
       
    Page 6 of 8 pages

     
     
    Item 10.
    Certification


    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated this 4th day of February, 2022.

     
    AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)
       
      AMERICAN CENTURY COMPANIES, INC. (“ACC”)
       
       
     
    By:
    /s/ John Pak
       
    John Pak
       
    Senior Vice President, ACIM and ACC
       
     
    STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC
       
       
     
    By:
    /s/ Richard W. Brown
       
    Richard W. Brown
       
    Chairman


    SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b).

    EXHIBIT A

    This Exhibit has been prepared to identify each subsidiary of American Century Companies, Inc. (“ACC”), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are the subject of this schedule (the “Subject Securities”).  American Century Investment Management, Inc. (“ACIM”) is a wholly-owned subsidiary of ACC and an investment adviser registered under §203 of the Investment Advisers Act of 1940.


    Page 7 of 8 pages

     
     
    SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b) and Rule 13d-1(f) (1) Agreement.

    EXHIBIT B

    Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule.

    Dated this 4th day of February, 2022.

     
    AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)
       
      AMERICAN CENTURY COMPANIES, INC. (“ACC”)
       
       
     
    By:
    /s/ John Pak
       
    John Pak
       
    Senior Vice President, ACIM and ACC
       
     
    STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC
       
       
     
    By:
    /s/ Richard W. Brown
       
    Richard W. Brown
       
    Chairman
     
    Page 8 of 8 pages

     

    Get the next $APR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APR

    DatePrice TargetRatingAnalyst
    1/11/2022$37.50Buy → Neutral
    UBS
    1/10/2022$39.00Buy
    Citigroup
    11/19/2021$39.00Buy
    Citigroup
    11/8/2021$43.00Buy
    Citigroup
    7/19/2021$32.00 → $29.00Buy → Neutral
    Goldman Sachs
    6/30/2021$33.00Buy
    Citigroup
    More analyst ratings

    $APR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Walker Robert P. returned $192,450 worth of shares to the company (5,132 units at $37.50), closing all direct ownership in the company (tax liability)

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:49 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 4: Apria Holdings Llc sold $532,031,812 worth of shares (14,187,515 units at $37.50)

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:15 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Snyder Lynn Shapiro to satisfy withholding obligation

    4 - Apria, Inc. (0001735803) (Issuer)

    3/29/22 4:31:20 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Apria Announces Financial Results for Fourth Quarter and Full Year 2021

    INDIANAPOLIS, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the fourth quarter and full year ended December 31, 2021. As previously announced, the Company will not be hosting a conference call to discuss its financial results. "We reported solid fourth quarter financial results and 2021 was a good year for Apria. Our team did an excellent job operating and executing at a high level while navigating the challenges from the COVID-19 pandemic, as well as a major product recall and supply chain constraints. Fourth

    2/28/22 6:30:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Apria Announces Expiration of Hart-Scott-Rodino Waiting Period

    INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its previously announced transaction with Owens & Minor, Inc. The closing of the transaction remains subject to approval by holders of a majority of the Company's outstanding common stock and other customary closing conditions. About Apria Apria is a leading provider of integrated home healthcare equipment and related services in the United States,

    2/24/22 4:05:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

    Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

    1/10/22 6:00:00 AM ET
    $APR
    $OMI
    Medical/Dental Instruments
    Health Care
    Medical Specialities

    $APR
    SEC Filings

    View All

    SEC Form 15-12B filed by Apria Inc.

    15-12B - Apria, Inc. (0001735803) (Filer)

    4/8/22 10:10:58 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form 25-NSE filed by Apria Inc.

    25-NSE - Apria, Inc. (0001735803) (Subject)

    3/29/22 8:55:14 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Apria Inc.

    S-8 POS - Apria, Inc. (0001735803) (Filer)

    3/29/22 8:35:01 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Apria downgraded by UBS with a new price target

    UBS downgraded Apria from Buy to Neutral and set a new price target of $37.50

    1/11/22 6:43:54 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Apria with a new price target

    Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

    1/10/22 7:15:48 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Apria with a new price target

    Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00

    11/19/21 7:12:27 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Leadership Updates

    Live Leadership Updates

    View All

    Apria Appoints Christopher G. Lee as Chief Accounting Officer

    INDIANAPOLIS, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today the appointment of Christopher G. Lee as Chief Accounting Officer, a newly created position. Mr. Lee will report to Debra Morris, Apria's Chief Financial Officer. Mr. Lee has 18 years of accounting and financial leadership experience. He joined Apria in February 2009 and has risen internally to his most recent role as Senior Vice President, Accounting and Finance. Prior to joining Apria, Mr. Lee was with Deloitte & Touche. Mr. Lee is a graduate of the University of California a

    10/4/21 8:00:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Apria Inc. (Amendment)

    SC 13G/A - Apria, Inc. (0001735803) (Subject)

    4/8/22 4:04:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Apria Inc.

    SC 13G - Apria, Inc. (0001735803) (Subject)

    3/10/22 5:01:54 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Apria Inc.

    SC 13G - Apria, Inc. (0001735803) (Subject)

    2/14/22 4:06:09 PM ET
    $APR
    Medical/Dental Instruments
    Health Care

    $APR
    Financials

    Live finance-specific insights

    View All

    Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

    Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil

    1/10/22 6:00:00 AM ET
    $APR
    $OMI
    Medical/Dental Instruments
    Health Care
    Medical Specialities

    Apria to Announce Third Quarter 2021 Financial Results

    INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal third quarter 2021 financial results on Thursday, November 4, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID 4161279; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listeni

    10/21/21 8:00:00 AM ET
    $APR
    Medical/Dental Instruments
    Health Care

    Apria to Announce Second Quarter 2021 Financial Results

    INDIANAPOLIS, July 22, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal second quarter 2021 financial results on Thursday, August 5, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID # 5380517; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listen

    7/22/21 4:05:00 PM ET
    $APR
    Medical/Dental Instruments
    Health Care